| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ONECUT2 VEZF1 RBPJL SOX30 NR4A2 E2F2 E4F1 NR3C1 MLXIP ONECUT1 NFATC2 NFATC3 RBPJ TBX20 NOTCH1 CREB3L2 MYBL2 | 4.23e-08 | 560 | 120 | 17 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ONECUT2 VEZF1 RBPJL SOX30 NR4A2 E2F2 E4F1 NR3C1 MLXIP ONECUT1 NFATC2 NFATC3 RBPJ TBX20 NOTCH1 CREB3L2 MYBL2 | 4.93e-08 | 566 | 120 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ONECUT2 ZNF652 RBPJL SOX30 NR4A2 NSD1 E2F2 E4F1 POU6F1 NR3C1 MLXIP ONECUT1 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 MNT NOTCH1 CREB3L2 MYBL2 | 6.22e-06 | 1271 | 120 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ONECUT2 VEZF1 ZNF652 RBPJL SOX30 NR4A2 E2F2 E4F1 POU6F1 NR3C1 MLXIP ZHX2 ONECUT1 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 MNT NOTCH1 CREB3L2 MYBL2 | 1.00e-05 | 1412 | 120 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 PCLO NR4A2 NSD1 TACC2 E4F1 CAMTA2 NR3C1 GSK3B YEATS2 SALL1 NFATC2 NFATC3 RBPJ TBX20 DCP1A | 1.14e-05 | 753 | 120 | 16 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ONECUT2 ZNF652 RBPJL SOX30 NR4A2 NSD1 E2F2 E4F1 POU6F1 NR3C1 MLXIP ONECUT1 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 MNT CREB3L2 MYBL2 | 1.52e-05 | 1244 | 120 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ONECUT2 VEZF1 ZNF652 RBPJL SOX30 NR4A2 NSD1 E2F2 E4F1 POU6F1 NR3C1 MLXIP ONECUT1 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 MNT CREB3L2 MYBL2 | 5.23e-05 | 1459 | 120 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.37e-04 | 320 | 120 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.42e-04 | 188 | 120 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.58e-04 | 326 | 120 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | A-type (transient outward) potassium channel activity | 2.13e-04 | 4 | 120 | 2 | GO:0005250 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 3.54e-04 | 5 | 120 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | chromatin binding | RBPJL NSD1 CAMTA2 NR3C1 MBD6 ONECUT1 SALL1 NFATC2 NFATC3 RBPJ CABIN1 MNT NOTCH1 | 5.05e-04 | 739 | 120 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 9.79e-04 | 8 | 120 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 1.56e-03 | 10 | 120 | 2 | GO:0140537 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SCAF8 SOX30 BCORL1 NR4A2 NSD1 E4F1 POU6F1 NR3C1 PPP1R15A ZHX2 TENM2 YEATS2 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 SAP130 MNT NOTCH1 | 7.87e-07 | 1053 | 121 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ONECUT2 VEZF1 RBPJL SOX30 NR4A2 E2F2 E4F1 CAMTA2 NR3C1 MLXIP ONECUT1 GSK3B SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 NOTCH1 MRTFA CREB3L2 MYBL2 | 1.75e-05 | 1390 | 121 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of ephrin receptor signaling pathway | 3.41e-05 | 2 | 121 | 2 | GO:1901189 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SCAF8 SOX30 BCORL1 NR4A2 NSD1 E4F1 POU6F1 NR3C1 PPP1R15A ZHX2 TENM2 YEATS2 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 SAP130 MNT NOTCH1 | 6.05e-05 | 1399 | 121 | 21 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SCAF8 SOX30 BCORL1 NR4A2 NSD1 E4F1 POU6F1 NR3C1 PPP1R15A ZHX2 TENM2 YEATS2 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 SAP130 MNT NOTCH1 | 6.98e-05 | 1413 | 121 | 21 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion involved in heart morphogenesis | 1.02e-04 | 3 | 121 | 2 | GO:0061344 | |
| GeneOntologyBiologicalProcess | organelle assembly | ONECUT2 TCTN3 LRFN1 VPS37A SOX30 IST1 ONECUT1 GSK3B CFAP65 NRXN3 NRXN2 STARD9 CFAP74 TMEM39A DYNC1H1 NOTCH1 MYBPC1 MYBL2 | 1.13e-04 | 1138 | 121 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | PCLO NR3C1 DCC GRM6 TENM2 GSK3B EFR3A SLC6A9 NRXN3 NRXN2 KCND2 LPA RIMBP2 IGSF9B NOTCH1 GABRA6 | 1.21e-04 | 939 | 121 | 16 | GO:0099537 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ROBO4 HSPG2 SPEM3 VEZF1 ERVFC1 SOX30 EPB41L5 IFITM1 E2F2 PPP1R15A GSK3B SETD2 NRXN3 SALL1 NFATC2 NFATC3 LPA RBPJ TBX20 NOTCH1 MYBPC1 | 1.38e-04 | 1483 | 121 | 21 | GO:0048646 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 1.65e-04 | 138 | 121 | 6 | GO:0055017 | |
| GeneOntologyBiologicalProcess | endoderm development | 1.70e-04 | 88 | 121 | 5 | GO:0007492 | |
| GeneOntologyBiologicalProcess | synaptic signaling | PCLO NR3C1 DCC GRM6 TENM2 GSK3B EFR3A SLC6A9 NRXN3 NRXN2 KCND2 LPA RIMBP2 IGSF9B NOTCH1 GABRA6 | 1.88e-04 | 976 | 121 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 1.92e-04 | 142 | 121 | 6 | GO:0003300 | |
| GeneOntologyBiologicalProcess | regulation of ephrin receptor signaling pathway | 2.03e-04 | 4 | 121 | 2 | GO:1901187 | |
| GeneOntologyBiologicalProcess | response to growth factor | ONECUT2 MXRA5 CTDSPL2 EPB41L5 NR3C1 ONECUT1 GSK3B KCND3 RBPJ ZFHX3 TBX20 SAP130 TNXB NOTCH1 DCP1A | 2.07e-04 | 883 | 121 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | central nervous system development | NES HSPG2 NR4A2 TACC2 POU6F1 MSI1 NR3C1 DCC GSK3B SETD2 SALL1 SEMA6D RBPJ PRKG1 TBX20 PDGFC NOTCH1 MRTFA | 2.12e-04 | 1197 | 121 | 18 | GO:0007417 |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 2.24e-04 | 146 | 121 | 6 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 2.41e-04 | 148 | 121 | 6 | GO:0014896 | |
| GeneOntologyBiologicalProcess | heart growth | 2.41e-04 | 148 | 121 | 6 | GO:0060419 | |
| GeneOntologyBiologicalProcess | circulatory system development | ROBO4 HSPG2 VEZF1 E2F2 POU6F1 NR3C1 PPP1R15A TRIP11 GSK3B GREB1L SETD2 NRXN3 SALL1 NFATC2 NFATC3 LPA RBPJ PRKG1 TBX20 NOTCH1 | 2.67e-04 | 1442 | 121 | 20 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle tissue growth | 3.27e-04 | 56 | 121 | 4 | GO:0055023 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ROBO4 NES HSPG2 NR4A2 IST1 DCC TENM2 GSK3B NRXN3 SEMA6D PRKG1 MUC3A SNX2 NOTCH1 | 3.49e-04 | 826 | 121 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | PCLO NR3C1 DCC GRM6 GSK3B EFR3A SLC6A9 NRXN3 NRXN2 KCND2 LPA RIMBP2 IGSF9B NOTCH1 GABRA6 | 3.64e-04 | 931 | 121 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | PCLO NR3C1 DCC GRM6 GSK3B EFR3A SLC6A9 NRXN3 NRXN2 KCND2 LPA RIMBP2 IGSF9B NOTCH1 GABRA6 | 3.64e-04 | 931 | 121 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.64e-04 | 24 | 121 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 3.78e-04 | 161 | 121 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 3.88e-04 | 299 | 121 | 8 | GO:0060560 | |
| GeneOntologyBiologicalProcess | positive regulation of heart growth | 4.26e-04 | 60 | 121 | 4 | GO:0060421 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 5.04e-04 | 6 | 121 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 5.04e-04 | 6 | 121 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 5.04e-04 | 6 | 121 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 5.04e-04 | 6 | 121 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | axonogenesis | ROBO4 HSPG2 NR4A2 IST1 DCC TENM2 GSK3B NRXN3 SEMA6D PRKG1 NOTCH1 | 5.06e-04 | 566 | 121 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | heart development | HSPG2 POU6F1 NR3C1 TRIP11 GSK3B GREB1L SETD2 SALL1 NFATC3 RBPJ PRKG1 TBX20 NOTCH1 | 5.06e-04 | 757 | 121 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | muscle structure development | CD164 POU6F1 NR3C1 GSK3B NFATC2 NFATC3 LPA RBPJ ZFHX3 PRKG1 TBX20 NOTCH1 MRTFA MYBPC1 | 5.09e-04 | 858 | 121 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | pericardium development | 5.80e-04 | 28 | 121 | 3 | GO:0060039 | |
| GeneOntologyBiologicalProcess | endocardium morphogenesis | 7.03e-04 | 7 | 121 | 2 | GO:0003160 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 7.03e-04 | 7 | 121 | 2 | GO:0007221 | |
| GeneOntologyCellularComponent | chromatin | ONECUT2 BICRA RBPJL SOX30 NR4A2 NSD1 IST1 E2F2 CAMTA2 POU6F1 NR3C1 MLXIP SRCAP ZHX2 ONECUT1 YEATS2 SALL1 NFATC2 NFATC3 RBPJ NFRKB ZFHX3 TBX20 SAP130 MNT CREB3L2 | 3.31e-07 | 1480 | 122 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | Golgi lumen | 3.53e-06 | 109 | 122 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | MAML1-RBP-Jkappa- ICN1 complex | 1.01e-04 | 3 | 122 | 2 | GO:0002193 | |
| GeneOntologyCellularComponent | postsynaptic membrane | LRFN1 DCC GRM6 TENM2 SLC6A9 KCND2 KCND3 IGSF9B NOTCH1 GABRA6 | 1.34e-04 | 405 | 122 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | chromocenter | 1.48e-04 | 18 | 122 | 3 | GO:0010369 | |
| GeneOntologyCellularComponent | synaptic membrane | LRFN1 DCC GRM6 TENM2 SLC6A9 NRXN3 NRXN2 KCND2 KCND3 IGSF9B NOTCH1 GABRA6 | 1.58e-04 | 583 | 122 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic specialization | LRFN1 PCLO NR3C1 DCC GSK3B SLC6A9 KCND2 KCND3 IGSF9B NOTCH1 GABRA6 | 1.78e-04 | 503 | 122 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.06e-04 | 164 | 122 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 6.34e-04 | 29 | 122 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 RBPJL NR4A2 E2F2 MLXIP SALL1 NFATC2 NFATC3 RBPJ ZFHX3 DCP1A | 7.44e-04 | 596 | 122 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.18e-03 | 201 | 122 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.43e-03 | 141 | 122 | 5 | GO:0048786 | |
| Domain | EGF_3 | HSPG2 MUC3B SSPOP TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 2.91e-07 | 235 | 118 | 11 | PS50026 |
| Domain | EGF_1 | HSPG2 MUC3B SSPOP TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 6.54e-07 | 255 | 118 | 11 | PS00022 |
| Domain | fn3 | 8.87e-07 | 162 | 118 | 9 | PF00041 | |
| Domain | EGF_2 | HSPG2 MUC3B SSPOP TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 9.55e-07 | 265 | 118 | 11 | PS01186 |
| Domain | TIG | 1.38e-06 | 31 | 118 | 5 | PF01833 | |
| Domain | SEA | 1.44e-06 | 14 | 118 | 4 | SM00200 | |
| Domain | IPT | 1.62e-06 | 32 | 118 | 5 | IPR002909 | |
| Domain | EGF | HSPG2 MUC3B TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 2.44e-06 | 235 | 118 | 10 | SM00181 |
| Domain | FN3 | 2.67e-06 | 185 | 118 | 9 | SM00060 | |
| Domain | EGF-like_dom | HSPG2 MUC3B TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 4.09e-06 | 249 | 118 | 10 | IPR000742 |
| Domain | FN3 | 4.85e-06 | 199 | 118 | 9 | PS50853 | |
| Domain | EGF-like_CS | HSPG2 MUC3B TENM2 NRXN3 MALRD1 NRXN2 SUSD1 MUC3A TNXB NOTCH1 | 6.20e-06 | 261 | 118 | 10 | IPR013032 |
| Domain | FN3_dom | 7.22e-06 | 209 | 118 | 9 | IPR003961 | |
| Domain | Ig-like_fold | ROBO4 HSPG2 COL7A1 LRFN1 MXRA5 RBPJL CAMTA2 DCC PTPRG NFATC2 NFATC3 RBPJ RIMBP2 IGSF9B TNXB MYBPC1 | 9.42e-06 | 706 | 118 | 16 | IPR013783 |
| Domain | SEA | 1.22e-05 | 23 | 118 | 4 | PS50024 | |
| Domain | SEA_dom | 1.22e-05 | 23 | 118 | 4 | IPR000082 | |
| Domain | - | ROBO4 HSPG2 COL7A1 LRFN1 MXRA5 RBPJL DCC PTPRG NFATC2 NFATC3 RBPJ RIMBP2 IGSF9B TNXB MYBPC1 | 1.87e-05 | 663 | 118 | 15 | 2.60.40.10 |
| Domain | p53-like_TF_DNA-bd | 2.08e-05 | 53 | 118 | 5 | IPR008967 | |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 2.60.40.1450 | |
| Domain | LAG1-DNAbind | 3.96e-05 | 2 | 118 | 2 | PF09271 | |
| Domain | BTD | 3.96e-05 | 2 | 118 | 2 | PF09270 | |
| Domain | BTD | 3.96e-05 | 2 | 118 | 2 | SM01268 | |
| Domain | LAG1_DNAbind | 3.96e-05 | 2 | 118 | 2 | SM01267 | |
| Domain | Beta-trefoil_DNA-bd_dom | 3.96e-05 | 2 | 118 | 2 | IPR015350 | |
| Domain | LAG1_DNA-bd | 3.96e-05 | 2 | 118 | 2 | IPR015351 | |
| Domain | C8 | 5.19e-05 | 12 | 118 | 3 | PF08742 | |
| Domain | TIL | 5.19e-05 | 12 | 118 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 6.71e-05 | 13 | 118 | 3 | IPR014853 | |
| Domain | C8 | 6.71e-05 | 13 | 118 | 3 | SM00832 | |
| Domain | TIL_dom | 8.51e-05 | 14 | 118 | 3 | IPR002919 | |
| Domain | Shal-type_N | 1.18e-04 | 3 | 118 | 2 | IPR021645 | |
| Domain | K_chnl_volt-dep_Kv4_C | 1.18e-04 | 3 | 118 | 2 | IPR024587 | |
| Domain | DUF3399 | 1.18e-04 | 3 | 118 | 2 | PF11879 | |
| Domain | K_chnl_volt-dep_Kv4 | 1.18e-04 | 3 | 118 | 2 | IPR003975 | |
| Domain | Shal-type | 1.18e-04 | 3 | 118 | 2 | PF11601 | |
| Domain | VWF_type-D | 1.30e-04 | 16 | 118 | 3 | IPR001846 | |
| Domain | VWFD | 1.30e-04 | 16 | 118 | 3 | PS51233 | |
| Domain | VWD | 1.30e-04 | 16 | 118 | 3 | SM00216 | |
| Domain | VWD | 1.30e-04 | 16 | 118 | 3 | PF00094 | |
| Domain | EGF | 1.49e-04 | 126 | 118 | 6 | PF00008 | |
| Domain | Ig_I-set | 2.06e-04 | 190 | 118 | 7 | IPR013098 | |
| Domain | I-set | 2.06e-04 | 190 | 118 | 7 | PF07679 | |
| Domain | VWC_out | 2.21e-04 | 19 | 118 | 3 | SM00215 | |
| Domain | SEA | 3.47e-04 | 22 | 118 | 3 | PF01390 | |
| Domain | AWS | 3.91e-04 | 5 | 118 | 2 | SM00570 | |
| Domain | AWS | 3.91e-04 | 5 | 118 | 2 | PS51215 | |
| Domain | AWS_dom | 3.91e-04 | 5 | 118 | 2 | IPR006560 | |
| Domain | NFAT | 3.91e-04 | 5 | 118 | 2 | IPR008366 | |
| Domain | Cys_knot_C | 5.11e-04 | 25 | 118 | 3 | IPR006207 | |
| Domain | CTCK_2 | 5.11e-04 | 25 | 118 | 3 | PS01225 | |
| Domain | Ig_E-set | 5.17e-04 | 104 | 118 | 5 | IPR014756 | |
| Domain | - | 6.44e-04 | 27 | 118 | 3 | 1.10.260.40 | |
| Domain | IGc2 | 7.37e-04 | 235 | 118 | 7 | SM00408 | |
| Domain | Ig_sub2 | 7.37e-04 | 235 | 118 | 7 | IPR003598 | |
| Domain | Lambda_DNA-bd_dom | 7.97e-04 | 29 | 118 | 3 | IPR010982 | |
| Domain | CUT | 8.14e-04 | 7 | 118 | 2 | PS51042 | |
| Domain | CUT | 8.14e-04 | 7 | 118 | 2 | PF02376 | |
| Domain | Syndecan | 8.14e-04 | 7 | 118 | 2 | PF01034 | |
| Domain | CUT_dom | 8.14e-04 | 7 | 118 | 2 | IPR003350 | |
| Domain | Syndecan/Neurexin_dom | 8.14e-04 | 7 | 118 | 2 | IPR027789 | |
| Domain | CUT | 8.14e-04 | 7 | 118 | 2 | SM01109 | |
| Domain | Homeodomain-like | 1.23e-03 | 332 | 118 | 8 | IPR009057 | |
| Domain | RHD_dimer | 1.72e-03 | 10 | 118 | 2 | IPR032397 | |
| Domain | RHD_dimer | 1.72e-03 | 10 | 118 | 2 | PF16179 | |
| Domain | REL_1 | 1.72e-03 | 10 | 118 | 2 | PS01204 | |
| Domain | - | 1.72e-03 | 10 | 118 | 2 | 2.60.40.340 | |
| Domain | NFkB/Dor | 1.72e-03 | 10 | 118 | 2 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 1.72e-03 | 10 | 118 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 1.72e-03 | 10 | 118 | 2 | PF00554 | |
| Domain | REL_2 | 1.72e-03 | 10 | 118 | 2 | PS50254 | |
| Domain | LAM_G_DOMAIN | 1.77e-03 | 38 | 118 | 3 | PS50025 | |
| Domain | LDLR_class-A_CS | 2.05e-03 | 40 | 118 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 2.05e-03 | 40 | 118 | 3 | PF02210 | |
| Domain | VWF_dom | 2.36e-03 | 42 | 118 | 3 | IPR001007 | |
| Domain | LamG | 2.70e-03 | 44 | 118 | 3 | SM00282 | |
| Domain | Ldl_recept_a | 2.88e-03 | 45 | 118 | 3 | PF00057 | |
| Domain | - | 3.06e-03 | 46 | 118 | 3 | 4.10.400.10 | |
| Domain | Neurexin-like | 3.43e-03 | 14 | 118 | 2 | IPR003585 | |
| Domain | 4.1m | 3.43e-03 | 14 | 118 | 2 | SM00294 | |
| Domain | LDLRA_1 | 3.46e-03 | 48 | 118 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.67e-03 | 49 | 118 | 3 | IPR002172 | |
| Domain | LDLa | 3.67e-03 | 49 | 118 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.67e-03 | 49 | 118 | 3 | PS50068 | |
| Domain | START_lipid-bd_dom | 3.94e-03 | 15 | 118 | 2 | IPR002913 | |
| Domain | START | 3.94e-03 | 15 | 118 | 2 | PF01852 | |
| Domain | START | 3.94e-03 | 15 | 118 | 2 | PS50848 | |
| Domain | Post-SET_dom | 4.48e-03 | 16 | 118 | 2 | IPR003616 | |
| Domain | PostSET | 4.48e-03 | 16 | 118 | 2 | SM00508 | |
| Domain | POST_SET | 4.48e-03 | 16 | 118 | 2 | PS50868 | |
| Domain | CTCK_1 | 5.67e-03 | 18 | 118 | 2 | PS01185 | |
| Domain | Laminin_G | 5.89e-03 | 58 | 118 | 3 | IPR001791 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.02e-06 | 16 | 84 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.63e-06 | 17 | 84 | 4 | M27412 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.04e-06 | 68 | 84 | 6 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.53e-06 | 23 | 84 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.59e-05 | 26 | 84 | 4 | M27483 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.25e-05 | 143 | 84 | 7 | M27275 | |
| Pathway | WP_PTF1A_RELATED_REGULATORY_PATHWAY | 3.25e-05 | 11 | 84 | 3 | M39548 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.16e-05 | 65 | 84 | 5 | M39682 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.32e-05 | 12 | 84 | 3 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.32e-05 | 12 | 84 | 3 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.32e-05 | 12 | 84 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 4.32e-05 | 12 | 84 | 3 | M47533 | |
| Pathway | WP_PTF1A_RELATED_REGULATORY_PATHWAY | 5.59e-05 | 13 | 84 | 3 | MM15904 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.59e-05 | 13 | 84 | 3 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 5.59e-05 | 13 | 84 | 3 | M47534 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 7.09e-05 | 14 | 84 | 3 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 7.09e-05 | 14 | 84 | 3 | M16173 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.08e-04 | 16 | 84 | 3 | M27121 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.08e-04 | 16 | 84 | 3 | M47424 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.34e-04 | 132 | 84 | 6 | M48110 | |
| Pathway | PID_PS1_PATHWAY | 1.58e-04 | 46 | 84 | 4 | M70 | |
| Pathway | WP_HEART_DEVELOPMENT | 1.58e-04 | 46 | 84 | 4 | MM15884 | |
| Pathway | WP_HEART_DEVELOPMENT | 1.72e-04 | 47 | 84 | 4 | M39610 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.86e-04 | 140 | 84 | 6 | M27484 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.51e-04 | 21 | 84 | 3 | MM15706 | |
| Pathway | PID_NFAT_3PATHWAY | 2.75e-04 | 53 | 84 | 4 | M113 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.03e-04 | 62 | 84 | 4 | M546 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 5.18e-04 | 6 | 84 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 5.18e-04 | 6 | 84 | 2 | M22074 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.21e-04 | 111 | 84 | 5 | M27416 | |
| Pathway | PID_TCR_CALCIUM_PATHWAY | 6.00e-04 | 28 | 84 | 3 | M235 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 6.76e-04 | 67 | 84 | 4 | MM15327 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.19e-04 | 250 | 84 | 7 | M27554 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 7.23e-04 | 7 | 84 | 2 | M27457 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 7.23e-04 | 7 | 84 | 2 | MM15199 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.94e-04 | 32 | 84 | 3 | MM15326 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.03e-03 | 129 | 84 | 5 | M5539 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.03e-03 | 75 | 84 | 4 | M5436 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.23e-03 | 9 | 84 | 2 | M27106 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.53e-03 | 10 | 84 | 2 | MM15535 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.63e-03 | 143 | 84 | 5 | M39591 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.79e-03 | 87 | 84 | 4 | M27617 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.86e-03 | 11 | 84 | 2 | MM14810 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.86e-03 | 11 | 84 | 2 | M27466 | |
| Pathway | KEGG_PROSTATE_CANCER | 1.95e-03 | 89 | 84 | 4 | M13191 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.98e-03 | 42 | 84 | 3 | M17541 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ONECUT2 RBPJL SOX30 NR4A2 E2F2 E4F1 CAMTA2 POU6F1 NR3C1 MLXIP ZHX2 ONECUT1 YEATS2 SALL1 NFATC2 NFATC3 RBPJ ZFHX3 TBX20 MNT CREB3L2 MYBL2 | 1.30e-12 | 908 | 124 | 22 | 19274049 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 BCORL1 E2F2 TACC2 NR3C1 SRCAP TRIP11 GSK3B YEATS2 SETD2 SALL1 NFATC3 RBPJ MYBL2 | 2.65e-08 | 588 | 124 | 14 | 38580884 |
| Pubmed | SCAF8 IST1 CAMTA2 MLXIP ZHX2 TENM2 YEATS2 SEMA6D STARD9 RIMBP2 DYNC1H1 SON | 2.75e-08 | 407 | 124 | 12 | 12693553 | |
| Pubmed | ONECUT2 VEZF1 TUT7 E2F2 NR3C1 SRCAP ONECUT1 SALL1 MBNL2 RBPJ ZFHX3 TBX20 MNT MRTFA CREB3L2 MYBL2 | 3.28e-08 | 808 | 124 | 16 | 20412781 | |
| Pubmed | HSPG2 VEZF1 SCAF8 BICRA BCORL1 PROSER1 SRCAP MBD6 ZHX2 YEATS2 SALL1 NFATC3 RBPJ NFRKB ZFHX3 CABIN1 SAP130 MNT DYNC1H1 DCP1A MYBL2 | 3.49e-08 | 1429 | 124 | 21 | 35140242 | |
| Pubmed | Intrahepatic bile duct regeneration in mice does not require Hnf6 or Notch signaling through Rbpj. | 4.42e-08 | 3 | 124 | 3 | 24631193 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ONECUT2 VEZF1 CTDSPL2 BCORL1 NSD1 E4F1 MLXIP SRCAP YEATS2 SETD2 RBPJ NFRKB CABIN1 CDC27 SAP130 MNT SON CREB3L2 MYBL2 | 1.71e-07 | 1294 | 124 | 19 | 30804502 |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 30932281 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 21558417 | ||
| Pubmed | VEZF1 TUT7 NR4A2 E2F2 TACC2 E4F1 POU6F1 NR3C1 ONECUT1 NFATC2 ZFHX3 MNT DCP1A MYBL2 | 2.60e-07 | 709 | 124 | 14 | 22988430 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | E4F1 NR3C1 SALL1 NFATC2 RBPJ CABIN1 CDC27 SAP130 NBR1 MNT DYNC1H1 SNX2 NOTCH1 DCP1A MYBL2 | 4.38e-07 | 857 | 124 | 15 | 25609649 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SPATA31E1 CTDSPL2 BICRA SALL1 IGSF9B EIF4G3 SAP130 DYNC1H1 NOTCH1 MRTFA SON | 4.40e-07 | 430 | 124 | 11 | 35044719 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.53e-07 | 18 | 124 | 4 | 18834073 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ONECUT2 SOX30 NR4A2 E2F2 POU6F1 NR3C1 ONECUT1 NFATC2 MBNL2 NFATC3 TBX20 MYBL2 | 6.19e-07 | 544 | 124 | 12 | 28473536 |
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 9111338 | ||
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 19110483 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 VPS37A SCAF8 BICRA HECTD4 ZHX2 SSPOP YEATS2 PTPRG MBNL2 KCND3 ZFHX3 IGSF9B EIF4G3 ZNF839 SAP130 NBR1 SNX2 CREB3L2 | 1.41e-06 | 1489 | 124 | 19 | 28611215 |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 2.17e-06 | 26 | 124 | 4 | 19369401 | |
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 15509736 | ||
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 28530678 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | NES IFITM1 ONECUT1 GSK3B SALL1 RBPJ ZFHX3 PDGFC NOTCH1 MYBL2 | 3.09e-06 | 424 | 124 | 10 | 21731673 |
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 4.63e-06 | 68 | 124 | 5 | 31112136 | |
| Pubmed | Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors. | 9.51e-06 | 12 | 124 | 3 | 18351630 | |
| Pubmed | CCHCR1 HSPG2 IST1 MBD6 ZHX2 SSPOP TRIP11 SETD2 NBR1 NOTCH1 CCDC33 | 1.21e-05 | 608 | 124 | 11 | 16713569 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22279105 | ||
| Pubmed | Role of CSL-dependent and independent Notch signaling pathways in cell apoptosis. | 1.26e-05 | 2 | 124 | 2 | 26496776 | |
| Pubmed | Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription. | 1.26e-05 | 2 | 124 | 2 | 17284587 | |
| Pubmed | RAM-induced allostery facilitates assembly of a notch pathway active transcription complex. | 1.26e-05 | 2 | 124 | 2 | 18381292 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 36050315 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34316028 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32209671 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28754676 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31060750 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10430878 | ||
| Pubmed | Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. | 1.26e-05 | 2 | 124 | 2 | 9826771 | |
| Pubmed | Glycogen synthase kinase 3β inhibition enhances Notch1 recycling. | 1.26e-05 | 2 | 124 | 2 | 29237816 | |
| Pubmed | Glycogen synthase kinase-3beta modulates notch signaling and stability. | 1.26e-05 | 2 | 124 | 2 | 12123574 | |
| Pubmed | Dynamic response diversity of NFAT isoforms in individual living cells. | 1.26e-05 | 2 | 124 | 2 | 23219532 | |
| Pubmed | "Notch-Off": a perspective on the termination of Notch signalling. | 1.26e-05 | 2 | 124 | 2 | 19247952 | |
| Pubmed | Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation. | 1.26e-05 | 2 | 124 | 2 | 37553428 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18838540 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11532000 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9111040 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23583303 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17070841 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 1.26e-05 | 2 | 124 | 2 | 10973822 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31344256 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17513037 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24637115 | ||
| Pubmed | Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. | 1.26e-05 | 2 | 124 | 2 | 19562035 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22640738 | ||
| Pubmed | Dose-dependent regulation of horizontal cell fate by Onecut family of transcription factors. | 1.26e-05 | 2 | 124 | 2 | 32790713 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8749394 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22771494 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19193882 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15563876 | ||
| Pubmed | Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes. | 1.26e-05 | 2 | 124 | 2 | 26196737 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10942109 | ||
| Pubmed | Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis. | 1.26e-05 | 2 | 124 | 2 | 21637838 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29790931 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15657288 | ||
| Pubmed | Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. | 1.26e-05 | 2 | 124 | 2 | 9846484 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21493891 | ||
| Pubmed | Band-pass processing in a GPCR signaling pathway selects for NFAT transcription factor activation. | 1.26e-05 | 2 | 124 | 2 | 26374065 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27055860 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19107229 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33813076 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9498773 | ||
| Pubmed | Distinct spatial Ca2+ signatures selectively activate different NFAT transcription factor isoforms. | 1.26e-05 | 2 | 124 | 2 | 25818645 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34386734 | ||
| Pubmed | Common variants in the MKL1 gene confer risk of schizophrenia. | 1.26e-05 | 2 | 124 | 2 | 25380769 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12958310 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20231377 | ||
| Pubmed | Nuclear factor of activated T-cells (NFAT)C2 inhibits Notch receptor signaling in osteoblasts. | 1.26e-05 | 2 | 124 | 2 | 23166323 | |
| Pubmed | GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression. | 1.26e-05 | 2 | 124 | 2 | 26823495 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21737748 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25512468 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28423575 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9843794 | ||
| Pubmed | A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. | 1.26e-05 | 2 | 124 | 2 | 16051745 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10637481 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9334251 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27863227 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12145413 | ||
| Pubmed | Transgenic expression of Notch in melanocytes demonstrates RBP-Jkappa-dependent signaling. | 1.26e-05 | 2 | 124 | 2 | 19895548 | |
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 1.26e-05 | 2 | 124 | 2 | 2393399 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11289722 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17122053 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 38771044 | ||
| Pubmed | Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. | 1.26e-05 | 2 | 124 | 2 | 18157086 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 1.26e-05 | 2 | 124 | 2 | 10405327 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17977834 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.37e-05 | 398 | 124 | 9 | 35016035 | |
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 1.56e-05 | 14 | 124 | 3 | 23217742 | |
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 22797898 | ||
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 23213462 | ||
| Pubmed | 1.95e-05 | 15 | 124 | 3 | 26522984 | ||
| Pubmed | 2.39e-05 | 16 | 124 | 3 | 12787506 | ||
| Pubmed | 2.39e-05 | 16 | 124 | 3 | 28434801 | ||
| Pubmed | VEZF1 SCAF8 ZNF652 NSD1 EPB41L5 IST1 E4F1 ZHX2 EFR3A GREB1L SETD2 NFATC2 NFRKB ZFHX3 EIF4G3 CDC27 SON | 2.41e-05 | 1497 | 124 | 17 | 31527615 | |
| Interaction | TLE3 interactions | VEZF1 SCAF8 BCORL1 PROSER1 NR3C1 GSK3B SETD2 SALL1 NFRKB ZFHX3 TBX20 SAP130 NOTCH1 SON MYBL2 | 7.86e-09 | 376 | 121 | 15 | int:TLE3 |
| Interaction | ASF1A interactions | BDP1 BICRA BCORL1 NSD1 SRCAP YEATS2 NFRKB CABIN1 SAP130 MYBL2 | 2.64e-06 | 249 | 121 | 10 | int:ASF1A |
| Interaction | NFIX interactions | 9.43e-06 | 227 | 121 | 9 | int:NFIX | |
| GeneFamily | CD molecules|Mucins | 2.53e-08 | 21 | 78 | 5 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 4.38e-07 | 160 | 78 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.06e-06 | 161 | 78 | 7 | 593 | |
| GeneFamily | Nuclear factors of activated T-cells | 1.82e-04 | 5 | 78 | 2 | 665 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 6.49e-04 | 9 | 78 | 2 | 527 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.86e-03 | 15 | 78 | 2 | 759 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.86e-03 | 15 | 78 | 2 | 529 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VEZF1 SCAF8 NR3C1 ZHX2 GSK3B EFR3A SETD2 NFATC3 RBPJ ZFHX3 ATP13A3 EIF4G3 CDC27 MNT SNX2 MRTFA SON CREB3L2 | 7.13e-08 | 856 | 120 | 18 | M4500 |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 9.75e-08 | 171 | 120 | 9 | M8594 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SCAF8 E2F2 NR3C1 ZHX2 GSK3B SETD2 RBPJ ATP13A3 EIF4G3 CDC27 CREB3L2 | 1.02e-05 | 466 | 120 | 11 | M13522 |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 1.37e-05 | 170 | 120 | 7 | M9445 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 3.77e-05 | 199 | 120 | 7 | M7259 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 VEZF1 SCAF8 ZNF652 HECTD4 NR4A2 NSD1 IFITM1 NR3C1 PPP1R15A EFR3A SETD2 NFATC2 NFATC3 RBPJ DYNC1H1 NOTCH1 DCP1A SON | 4.76e-05 | 1492 | 120 | 19 | M40023 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | GARNL3 PRR36 MFSD6 EPB41L5 PODXL2 POU6F1 SELENOV FRRS1 NRXN3 NRXN2 | 1.38e-06 | 248 | 119 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | COL7A1 GARNL3 PRR36 MFSD6 EPB41L5 PODXL2 POU6F1 NR3C1 TENM2 GREB1L SLC6A9 SELENOV FRRS1 NRXN3 SALL1 NRXN2 PDGFC CCDC33 MYBL2 | 2.04e-06 | 976 | 119 | 19 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 EPB41L5 E2F2 PODXL2 POU6F1 DCC SELENOV FRRS1 NRXN3 NRXN2 STARD9 | 3.33e-06 | 732 | 119 | 16 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | NES COL7A1 GARNL3 PRR36 MFSD6 E2F2 PODXL2 POU6F1 NR3C1 DCC SELENOV NRXN3 | 8.12e-06 | 447 | 119 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL7A1 GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 E2F2 PODXL2 POU6F1 DCC SELENOV NRXN3 NRXN2 NFRKB | 1.24e-05 | 721 | 119 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | NES PRR36 PCLO MFSD6 EPB41L5 MSI1 DCC TENM2 NRXN3 SALL1 NRXN2 NOTCH1 | 1.72e-05 | 482 | 119 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | NES GARNL3 PRR36 PCLO MFSD6 EPB41L5 E2F2 DCC SELENOV NRXN3 SALL1 NRXN2 | 2.28e-05 | 496 | 119 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.63e-05 | 212 | 119 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | GARNL3 PRR36 PCLO MFSD6 NR4A2 EPB41L5 E2F2 PODXL2 POU6F1 MSI1 DCC SELENOV NRXN3 NRXN2 | 2.92e-05 | 683 | 119 | 14 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | NES PRR36 CTDSPL2 PCLO MFSD6 EPB41L5 MSI1 PLEKHG2 DCC TENM2 EFR3A NRXN3 SALL1 NRXN2 CFAP74 NBR1 NOTCH1 | 3.24e-05 | 979 | 119 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.76e-05 | 306 | 119 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.21e-05 | 121 | 119 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.11e-05 | 124 | 119 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.03e-04 | 330 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.26e-04 | 339 | 119 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 STARD8 PRR36 CTDSPL2 PCLO MFSD6 IFITM1 PLEKHG2 PPP1R15A EFR3A CFAP74 ZFHX3 ATP13A3 PDGFC MUC6 MNT | 1.29e-04 | 989 | 119 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | NES GARNL3 PRR36 PCLO MFSD6 NR4A2 EPB41L5 E2F2 PODXL2 POU6F1 MSI1 DCC SELENOV NRXN3 NRXN2 | 1.42e-04 | 893 | 119 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 1.56e-04 | 19 | 119 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 1.68e-04 | 145 | 119 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NES GARNL3 PRR36 PCLO MFSD6 HECTD4 E2F2 PODXL2 POU6F1 DCC SELENOV NRXN2 | 1.74e-04 | 614 | 119 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | RELCH NSD1 MSI1 TENM2 GSK3B EFR3A NRXN3 SALL1 PTPRG KCND2 RBPJ ATP13A3 PRKG1 TBX20 | 1.98e-04 | 818 | 119 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | RELCH MSI1 TENM2 EFR3A NRXN3 PTPRG NRXN2 ZFHX3 ATP13A3 PRKG1 TBX20 PARM1 DCP1A SON | 1.98e-04 | 818 | 119 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 E2F2 PODXL2 POU6F1 DCC SELENOV SALL1 NRXN2 | 2.08e-04 | 722 | 119 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 E2F2 PODXL2 POU6F1 DCC SELENOV NRXN2 NFRKB | 2.31e-04 | 730 | 119 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.37e-04 | 369 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 E2F2 PODXL2 POU6F1 MSI1 DCC SELENOV NRXN2 | 2.88e-04 | 747 | 119 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | GARNL3 PRR36 PCLO MFSD6 HECTD4 NR4A2 E2F2 PODXL2 POU6F1 DCC SELENOV NRXN2 | 3.28e-04 | 658 | 119 | 12 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 3.29e-04 | 231 | 119 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 4.06e-04 | 111 | 119 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 NES GARNL3 PRR36 PCLO NR4A2 EPB41L5 DCC TENM2 SELENOV SETD2 FRRS1 SALL1 NRXN2 CFAP74 | 4.23e-04 | 989 | 119 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | BDP1 NES PRR36 PCLO EPB41L5 IFITM1 PROSER1 MSI1 ZHX2 GREB1L SELENOV SALL1 NRXN2 PARM1 MYBL2 | 4.32e-04 | 991 | 119 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | PRR36 EPB41L5 GREB1L SELENOV FRRS1 NRXN3 SALL1 NRXN2 CCDC33 MYBL2 | 4.34e-04 | 489 | 119 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 4.62e-04 | 493 | 119 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.91e-04 | 247 | 119 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 5.00e-04 | 498 | 119 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 5.01e-04 | 409 | 119 | 9 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 5.86e-04 | 183 | 119 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RELCH NSD1 TENM2 EFR3A SALL1 PTPRG KCND3 RBPJ ATP13A3 PRKG1 PDGFC CDC27 DCP1A | 5.92e-04 | 806 | 119 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.95e-04 | 419 | 119 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 6.16e-04 | 421 | 119 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.49e-04 | 127 | 119 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.07e-04 | 350 | 119 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-08 | 194 | 121 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-07 | 177 | 121 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 121 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.40e-07 | 188 | 121 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-06 | 155 | 121 | 6 | a16e3a72badafa78a3efc4f4ab62396f0ce99d1e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 178 | 121 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.05e-05 | 182 | 121 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 185 | 121 | 6 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 186 | 121 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.31e-05 | 189 | 121 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 190 | 121 | 6 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 192 | 121 | 6 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 192 | 121 | 6 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 192 | 121 | 6 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-05 | 198 | 121 | 6 | f701d06e3d7fd2192afae3698c5ec3c355e96da3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.79e-05 | 77 | 121 | 4 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.98e-05 | 152 | 121 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.39e-05 | 159 | 121 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 7.62e-05 | 160 | 121 | 5 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 8.31e-05 | 163 | 121 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.56e-05 | 164 | 121 | 5 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 168 | 121 | 5 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 168 | 121 | 5 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.86e-05 | 169 | 121 | 5 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 9.86e-05 | 169 | 121 | 5 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 1.04e-04 | 171 | 121 | 5 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 172 | 121 | 5 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.16e-04 | 175 | 121 | 5 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.19e-04 | 176 | 121 | 5 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 176 | 121 | 5 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 176 | 121 | 5 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 177 | 121 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 177 | 121 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 177 | 121 | 5 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 179 | 121 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-04 | 180 | 121 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-04 | 180 | 121 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 182 | 121 | 5 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 182 | 121 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.43e-04 | 183 | 121 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.43e-04 | 183 | 121 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 184 | 121 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 184 | 121 | 5 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 184 | 121 | 5 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 185 | 121 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 185 | 121 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 185 | 121 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-04 | 185 | 121 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 185 | 121 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.51e-04 | 185 | 121 | 5 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 185 | 121 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 185 | 121 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-04 | 186 | 121 | 5 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 186 | 121 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 186 | 121 | 5 | c7983281a290201567b398e9ea6baddb96c692bb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-04 | 186 | 121 | 5 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 186 | 121 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 187 | 121 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 187 | 121 | 5 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 187 | 121 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-04 | 187 | 121 | 5 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 187 | 121 | 5 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 187 | 121 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 187 | 121 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 187 | 121 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 187 | 121 | 5 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 188 | 121 | 5 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 188 | 121 | 5 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 188 | 121 | 5 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 188 | 121 | 5 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 188 | 121 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.62e-04 | 188 | 121 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 189 | 121 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 189 | 121 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 1.66e-04 | 189 | 121 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 190 | 121 | 5 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 190 | 121 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 190 | 121 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-04 | 191 | 121 | 5 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.75e-04 | 191 | 121 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-04 | 191 | 121 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 191 | 121 | 5 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-04 | 191 | 121 | 5 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| Drug | AC1L1GTT | NR4A2 GRM6 SETD2 KCND2 NFATC3 KCND3 PRKG1 CABIN1 MYBPC1 CREB3L2 | 5.26e-07 | 233 | 122 | 10 | CID000003837 |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | ZNF652 NR3C1 PPP1R15A TRIP11 SEMA6D MBNL2 KCND3 CABIN1 MRTFA | 1.14e-06 | 196 | 122 | 9 | 4125_DN |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.16e-06 | 177 | 122 | 8 | 4164_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.01e-05 | 194 | 122 | 8 | 3431_DN | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 2796_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 3941_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 3860_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 2898_UP | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 2.07e-05 | 104 | 122 | 6 | ctd:C000595015 | |
| Drug | rioprostil | 2.51e-05 | 32 | 122 | 4 | CID005311413 | |
| Drug | 1-norokadaone | 3.19e-05 | 12 | 122 | 3 | CID003309928 | |
| Drug | INCA-6 | 3.19e-05 | 12 | 122 | 3 | CID000230748 | |
| Drug | cellobiitol | 4.52e-05 | 37 | 122 | 4 | CID000003871 | |
| Drug | saran | 5.03e-05 | 38 | 122 | 4 | CID000062706 | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 7.78e-05 | 191 | 122 | 7 | 2900_UP | |
| Drug | Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 3715_UP | |
| Drug | inulin | 8.24e-05 | 133 | 122 | 6 | CID000024763 | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 3446_UP | |
| Drug | AC1Q5T39 | 8.51e-05 | 3 | 122 | 2 | CID000738039 | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 6165_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 3977_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 6803_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 3408_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 4813_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 2086_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3848_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 2326_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3831_DN | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 6017_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 4315_UP | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3899_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2890_UP | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 4553_UP | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 7010_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 3128_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 5515_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 1824_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 7174_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 6652_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 4413_UP | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 5415_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 4953_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HG-U133A | 1.04e-04 | 200 | 122 | 7 | 1952_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 2077_UP | |
| Disease | Adenoid Cystic Carcinoma | 3.65e-06 | 100 | 121 | 6 | C0010606 | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.70e-06 | 64 | 121 | 5 | DOID:4947 (is_marker_for) | |
| Disease | Aortic valve disorder | 4.99e-05 | 3 | 121 | 2 | cv:C1260873 | |
| Disease | reaction time measurement | HECTD4 TACC2 DCC TENM2 EFR3A SETD2 SEMA6D RBPJ ZFHX3 EIF4G3 CDC27 | 8.67e-05 | 658 | 121 | 11 | EFO_0008393 |
| Disease | Sotos' syndrome | 9.95e-05 | 4 | 121 | 2 | C0175695 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.65e-04 | 5 | 121 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Bicuspid aortic valve | 1.65e-04 | 5 | 121 | 2 | C0149630 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.89e-04 | 69 | 121 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | body weight | RELCH HECTD4 NR4A2 E4F1 DCC GSK3B EFR3A SETD2 NRXN3 SEMA6D PTPRG SUSD1 NFATC2 KCND3 ZFHX3 | 2.06e-04 | 1261 | 121 | 15 | EFO_0004338 |
| Disease | Adams Oliver syndrome | 2.47e-04 | 6 | 121 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 2.47e-04 | 6 | 121 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 2.47e-04 | 6 | 121 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 2.47e-04 | 6 | 121 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | smoking status measurement | BICRA HECTD4 DCC TENM2 NRXN3 SALL1 SEMA6D PTPRG NRXN2 KCND2 ZFHX3 IGSF9B EIF4G3 GABRA6 | 2.94e-04 | 1160 | 121 | 14 | EFO_0006527 |
| Disease | depressive symptom measurement | 3.84e-04 | 426 | 121 | 8 | EFO_0007006 | |
| Disease | Sudden Cardiac Arrest | 4.59e-04 | 8 | 121 | 2 | C1720824 | |
| Disease | underweight body mass index status | 5.89e-04 | 9 | 121 | 2 | EFO_0005936 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 5.89e-04 | 9 | 121 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | trauma exposure measurement | 7.32e-04 | 172 | 121 | 5 | EFO_0010703 | |
| Disease | Autistic Disorder | 7.44e-04 | 261 | 121 | 6 | C0004352 | |
| Disease | blood phosphate measurement | 7.71e-04 | 174 | 121 | 5 | EFO_0010972 | |
| Disease | brain ischemia (biomarker_via_orthology) | 8.39e-04 | 102 | 121 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | atrial fibrillation | 8.70e-04 | 371 | 121 | 7 | EFO_0000275 | |
| Disease | Congenital Abnormality | 8.95e-04 | 11 | 121 | 2 | C0000768 | |
| Disease | free androgen index | 9.11e-04 | 374 | 121 | 7 | EFO_0007005 | |
| Disease | metabolite measurement, body weight gain | 1.07e-03 | 12 | 121 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | waist-hip ratio, body mass index | 1.07e-03 | 12 | 121 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | phosphatidylcholine measurement | 1.15e-03 | 284 | 121 | 6 | EFO_0010226 | |
| Disease | unipolar depression | PCLO NR4A2 MUC5B DCC ZHX2 TRIP11 TENM2 SEMA6D PTPRG ZFHX3 KLHDC7A EIF4G3 PDGFC | 1.37e-03 | 1206 | 121 | 13 | EFO_0003761 |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 1.43e-03 | 200 | 121 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Antithrombotic agent use measurement | 1.51e-03 | 55 | 121 | 3 | EFO_0009925 | |
| Disease | hepatoblastoma (is_marker_for) | 1.69e-03 | 15 | 121 | 2 | DOID:687 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.74e-03 | 801 | 121 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | alcohol consumption measurement | ONECUT2 PCLO MFSD6 ENTHD1 DCC TENM2 NRXN3 SEMA6D NFATC2 KCND2 ZFHX3 IGSF9B CCDC33 | 1.78e-03 | 1242 | 121 | 13 | EFO_0007878 |
| Disease | Schizoaffective disorder-bipolar type | 1.93e-03 | 16 | 121 | 2 | EFO_0009965 | |
| Disease | pancreatitis | 1.93e-03 | 16 | 121 | 2 | EFO_0000278 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.93e-03 | 16 | 121 | 2 | C0334634 | |
| Disease | Abnormal behavior | 1.93e-03 | 16 | 121 | 2 | C0233514 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.23e-03 | 133 | 121 | 4 | EFO_0010092 | |
| Disease | testosterone measurement | STARD8 SPEM3 ZNF652 TUT7 BCORL1 NR3C1 SRCAP ONECUT1 SEMA6D PTPRG SUSD1 ZFHX3 RIMBP2 | 2.24e-03 | 1275 | 121 | 13 | EFO_0004908 |
| Disease | cigarettes per day measurement | 2.24e-03 | 438 | 121 | 7 | EFO_0006525 | |
| Disease | syndrome (implicated_via_orthology) | 2.44e-03 | 18 | 121 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | sinusitis (is_marker_for) | 2.44e-03 | 18 | 121 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | nephrotic syndrome (is_marker_for) | 2.44e-03 | 18 | 121 | 2 | DOID:1184 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 2.44e-03 | 18 | 121 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.51e-03 | 447 | 121 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | biological sex | 2.63e-03 | 230 | 121 | 5 | PATO_0000047 | |
| Disease | stroke, major depressive disorder | 2.72e-03 | 19 | 121 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | lifestyle measurement | 2.89e-03 | 235 | 121 | 5 | EFO_0010724 | |
| Disease | chronic kidney disease (is_marker_for) | 3.02e-03 | 20 | 121 | 2 | DOID:784 (is_marker_for) | |
| Disease | Manic Disorder | 3.14e-03 | 71 | 121 | 3 | C0024713 | |
| Disease | rosacea severity measurement | 3.20e-03 | 147 | 121 | 4 | EFO_0009180 | |
| Disease | haptoglobin measurement | 3.33e-03 | 21 | 121 | 2 | EFO_0004640 | |
| Disease | Schizophrenia | 3.50e-03 | 883 | 121 | 10 | C0036341 | |
| Disease | Amphetamine-Related Disorders | 3.66e-03 | 75 | 121 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 3.66e-03 | 75 | 121 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 3.66e-03 | 75 | 121 | 3 | C0236804 | |
| Disease | reticulocyte count | CCHCR1 HECTD4 IST1 E2F2 PPP1R15A ZHX2 GREB1L SUSD1 NFRKB PDGFC MYBL2 | 3.85e-03 | 1045 | 121 | 11 | EFO_0007986 |
| Disease | Disproportionate short stature | 3.95e-03 | 77 | 121 | 3 | C0878659 | |
| Disease | Paroxysmal atrial fibrillation | 3.96e-03 | 156 | 121 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.96e-03 | 156 | 121 | 4 | C3468561 | |
| Disease | unipolar depression, bipolar disorder | 3.96e-03 | 156 | 121 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Persistent atrial fibrillation | 3.96e-03 | 156 | 121 | 4 | C2585653 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 4.05e-03 | 157 | 121 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Manic | 4.09e-03 | 78 | 121 | 3 | C0338831 | |
| Disease | gut microbiome measurement, bone density | 4.09e-03 | 78 | 121 | 3 | EFO_0003923, EFO_0007874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSPRVVPNESIPIIP | 806 | P23470 | |
| IVSTPPSPLAALRVP | 116 | Q8N976 | |
| VLTLPVPEYTPTSIP | 2241 | A6H8Y1 | |
| TVNRDIPPLTAPVTP | 221 | Q05D32 | |
| SVGLPITPLSFPIPS | 426 | Q8N5R6 | |
| SLDIITITVPPALPA | 446 | Q9H7F0 | |
| LIQAPVPPSAPTLVL | 316 | Q5H9F3 | |
| IPAPTPQLSPALSTI | 521 | O94983 | |
| TIPLSPVLSPTLPAE | 311 | Q9NPI6 | |
| ILELTIRPPPSPSGT | 781 | Q14156 | |
| PIPPVLTTTATTPAA | 3971 | Q9HC84 | |
| PVTPVPLISTLELSG | 381 | Q9UBG7 | |
| LTLSVPVAPEVSPRP | 1371 | Q96L73 | |
| VLVTIEPSSPGPIPA | 2906 | P98160 | |
| VSPSVLPPSALPLDL | 171 | Q9NRA1 | |
| PSLLLPSVTPTTVTP | 241 | Q9NZ53 | |
| LTPIISNLPPTLETP | 336 | Q9P260 | |
| DPELPLLATPPSIVS | 246 | Q8IYW4 | |
| PTLLPDTPAIPLTAT | 2641 | Q8WXI7 | |
| QSIPSSPLPVTALPT | 5356 | Q8WXI7 | |
| PSPTTAVPLLVPFTL | 13001 | Q8WXI7 | |
| VPSPTTTGPLLVPFT | 13156 | Q8WXI7 | |
| PASPTQTPLLPATLT | 1246 | Q6W4X9 | |
| PAIPICSIPVTASLP | 381 | Q13469 | |
| RSPLLPVSVPTAPEV | 1391 | P43146 | |
| LPEPSQPILPSVLSL | 401 | Q96DN6 | |
| TTAIISIPTPPALTP | 611 | Q9UK17 | |
| ILPQESPALPTSLPS | 2456 | P46531 | |
| SPSPAVPLRVVPTLS | 226 | Q6P4R8 | |
| TPVTPTTPALPAIPI | 721 | Q6P4R8 | |
| PVTSLPLVTTPAPET | 46 | Q04900 | |
| TLTPPIIPSVASPTD | 631 | Q13976 | |
| ALEPPTSAPPTLALV | 676 | Q9P244 | |
| TSDITIFPPPISVEP | 641 | Q6ZU64 | |
| APPGILSTVSEIPLT | 3386 | Q9Y6V0 | |
| TIPPSILVTTLPTPN | 686 | Q02505 | |
| VVIPETPTQTPPVLT | 2571 | Q02505 | |
| SSVIPLPLPGVSTIP | 2876 | Q02505 | |
| IPIVSSLADPLDTPP | 351 | A8MUH7 | |
| LTPLQPLPPISTVSD | 106 | Q9UBC0 | |
| LTPLQPLPPISTVSD | 151 | O95948 | |
| IATLASSPLPPPVAV | 56 | Q14863 | |
| PVLVSPSPTYTPILE | 1216 | P48681 | |
| AIISIPTPPVTTPEG | 596 | Q9NZV8 | |
| ATPAPLTVIPIPVVT | 81 | Q99583 | |
| LTRAPILQSTPVTPP | 391 | Q16445 | |
| VPATLPQLTPTLVSL | 521 | P04150 | |
| PLSVSLPTNIVPPTT | 26 | Q6UWI2 | |
| ALTPSPSPLPLTIEE | 831 | Q9Y4D8 | |
| AERIPVPSSPVPIAT | 636 | Q6ZSS7 | |
| TEPLLSAPVPQTPLT | 356 | Q9C091 | |
| TPLPSAPVLPELTAI | 251 | O43347 | |
| IPNPTVIRTPSLPTA | 331 | Q86XN7 | |
| ILPIITEDSLDPPPV | 376 | P58401 | |
| ADLPTPPETSVPVTL | 1031 | Q5VYJ5 | |
| PPAQESILPTTALPT | 361 | Q9HAP2 | |
| VSLPDSLIAPPTAPS | 376 | Q9HAP2 | |
| PVSPSISSAPVPVEI | 416 | Q9HCM4 | |
| VTPPPFISPTSQLVI | 686 | O15303 | |
| PEITVTPPTPTLLSP | 2146 | Q9Y6J0 | |
| PPPSLVPLEATDSLL | 361 | Q14209 | |
| VPPTAPGTSLVLLVL | 271 | Q8WXQ3 | |
| TVVPLPTLPPVSHLT | 176 | Q6ZNA5 | |
| ELSSNPPLATILIPP | 366 | P49841 | |
| TAVAPPTVTPVPSLE | 111 | P08519 | |
| TAVAPPTVTPVPSLE | 681 | P08519 | |
| TPTVVPVPSTELPSE | 1361 | P08519 | |
| SCPLPPPVTDVSLEL | 491 | Q8TD31 | |
| EPTPIPTIATSPTIL | 451 | P07359 | |
| TEILPTTPVIVPGSP | 146 | Q5VZF2 | |
| FVLPELPSVPDTLPT | 321 | P53990 | |
| ITTVPLPTAPNIPII | 2521 | Q14204 | |
| LPTVLTLPTPDLPQT | 761 | Q5VTJ3 | |
| VSIVVTTPPEAPPAL | 856 | Q02388 | |
| PPEALPATPATTALL | 86 | Q66K89 | |
| LSVPASVIVSAPPPA | 716 | Q9NZM4 | |
| LTPIVPSNSLLTEPP | 16 | P60507 | |
| TIPPVVPTSLVQPSL | 706 | Q9UPN6 | |
| PVLPTLTTSVGLPLP | 546 | Q9NSC2 | |
| LTTSVGLPLPPTLPS | 551 | Q9NSC2 | |
| SPLTPSFGILPLETP | 276 | P30260 | |
| IVSIAELPLPPSPTT | 256 | O43432 | |
| ELPLPPSPTTVSSVA | 261 | O43432 | |
| LLPPDSPITISPSVG | 1076 | Q9C0B2 | |
| TDEPPPGLVPSVTLT | 131 | Q70SY1 | |
| ITPPTPISVGLAAIP | 876 | Q5VVW2 | |
| PIPALTQTLPSSSVP | 626 | O75807 | |
| LGPPPSTILPRSTVI | 11 | P13164 | |
| DLPSIPTDISSLPTP | 421 | Q9H195 | |
| SVIPTPLPGVSTIPL | 791 | Q9H195 | |
| SPPSPPVSLISALVR | 356 | P43354 | |
| SAVAAVPPELLVPPT | 576 | O15034 | |
| ILSSEPSPAVTPVTP | 91 | O60749 | |
| PSPAVTPVTPTTLIA | 96 | O60749 | |
| SAVPSTVAPLPLPAT | 3216 | A2VEC9 | |
| IPEVVELPPSLPRSS | 811 | Q14596 | |
| LPPRQPSALVPSVTE | 356 | P10244 | |
| PLLVEDPLATPPIAT | 336 | Q9HDB5 | |
| SLQTPPASLTTPPLE | 721 | Q9H6K5 | |
| IPPTSSPSLLPSAQL | 171 | Q9NT68 | |
| SAPILPGVVTSPELP | 611 | Q6ZUB1 | |
| LTPVLTPSPAGTSPL | 46 | P59797 | |
| VLTPAPAQIPTLVPT | 61 | P59797 | |
| VSLAPVSLPRVPSPE | 2521 | Q9P2P6 | |
| ISVPTTLPAPASAPL | 1441 | Q6ZRS2 | |
| TLPAPASAPLTIPIS | 1446 | Q6ZRS2 | |
| ALLTSVTPPLAPVVP | 1471 | Q6ZRS2 | |
| ALVPVPVSAPVPISA | 2456 | Q6ZRS2 | |
| PPSVPISASVTNLPL | 2531 | Q6ZRS2 | |
| TPLPPLLVCPTATVA | 2976 | Q6ZRS2 | |
| VFLSLPIIPPPDTST | 666 | Q9NZP6 | |
| PLLPPSLTNGTTIPT | 186 | Q969V6 | |
| TSLPVITVSLPPEPA | 76 | Q92502 | |
| LPTPAVQSPSPVTLF | 471 | O94993 | |
| PSSILLPAAPIPILS | 741 | Q8WZ75 | |
| VPVEPLDVPLPSTIR | 161 | Q13057 | |
| LDVPLPSTIRPASPV | 166 | Q13057 | |
| VLITLPAEPTLPPDA | 196 | Q8IZ63 | |
| SPLTLTTPVNLPTPV | 456 | Q14119 | |
| TLAPATTPVLAPTPA | 381 | A0A1B0GUW6 | |
| VPATTPAPIITPIPS | 421 | A0A1B0GUW6 | |
| TLAFPITTPEPLVLV | 601 | Q9UPX0 | |
| ITTPEPLVLVTPPRC | 606 | Q9UPX0 | |
| SAIGLPVPPITALIT | 41 | Q9NV64 | |
| VISLTTQITEPPLPE | 576 | Q6UWL2 | |
| LSTIPGAVPITPPIT | 741 | Q9H0E3 | |
| VVIVTAPLPPAPATE | 1556 | P22105 | |
| VSTVGITAPLPTPLP | 3246 | P22105 | |
| IFNVDPPPSTLTTPL | 46 | Q12968 | |
| PVAPSSPEQVTLLPV | 21 | P48067 | |
| LPVSPEPSLLTPTEE | 401 | O95359 | |
| TLSSPAPVTEPVALP | 201 | Q9BYW2 | |
| PVLAPVTPVPVVESL | 346 | Q06330 | |
| PTSVLPTEVAAPPLE | 671 | A8K0R7 | |
| VPPTITVLPAQLAPT | 341 | Q9Y6X8 | |
| ISDVLPTFTPLPALP | 1951 | Q15643 | |
| PATTPLPLPQVLTDI | 1141 | Q9H7P9 | |
| CTEPLIPTTPIIPSE | 81 | Q9UMR3 | |
| PGLPTVVPTLVTPSA | 61 | Q6NUS6 | |
| QEEELLTTLPPPTPS | 276 | Q5VYS8 | |
| IPLTTSPATPVPSVV | 506 | Q9Y2D9 | |
| PELAALPTPESTPVL | 766 | Q8NFY4 | |
| VTVLEPSVVTVPEPP | 1381 | P18583 | |
| PVPVVSALEPSVPVL | 1406 | P18583 | |
| NLPLPIPTVDASIPT | 201 | Q8NEZ2 | |
| SDISDAPPSLPLTIP | 346 | Q9ULM3 | |
| ITSPTIAPAQPSVPL | 2071 | Q15911 | |
| PSLSLEVTPPFPAIS | 811 | Q9NR99 | |
| PFVPLAVTSPPTLLT | 711 | Q00872 |